Results from Roche’s Phase Ib/IIa trial of new Alzheimer’s drug trontinemab were presented at the Alzheimer’s Association International Conference (AAIC) in Toronto this week. The trial, known as Brainshuttle™ AD, […]
Research led by Dr Sarah Marzi (UK DRI at King’s) with collaborators at Imperial College London and the University of Pittsburgh, reveals cells in key brain regions involved in Parkinson’s […]
A new study, led by Dr Sarah Marzi and Dr Kitty Murphy at the UK DRI at King’s and the Department of Basic and Clinical Neuroscience, offers clues into how APOE isoforms […]
Marking a pivotal moment in brain health research, the UK DRI has united with Parkinson’s UK to establish a new £10m research centre dedicated to better understanding the causes of Parkinson’s and […]